14 -8 (46) 2022 — Mamadjanova Shakhnoz Kahramonovna — THE ROLE OF HIRUDOTHERAPY IN TREATING ALGODYSMENORRHEA

THE ROLE OF HIRUDOTHERAPY IN TREATING ALGODYSMENORRHEA

Mamadjanova Shakhnoz Kahramonovna Andijan State Medical Institute

Resume

Algodysmenorrhea, also known as painful periods or menstrual cramps, is pain during menstruation . It is considered as one of the most common disorders of female reproductive system.Primary dysmenorrhea refers to recurrent pain, while secondary dysmenorrhea results from reproductive system disorders.[1]The condition interrupts  general well-being and reduces the productivity of women in daily activities. Therefore, this study was observed to evaluate the effectiveness of leech therapy on the improvement of dysmenorrhea. We conducted a research with 20 patients of reproductive age with a history of primary dysmenorrhea were examined.They were conducted the dopplemetric study of blood flow in the uterine arteries and endometrial thickness in the middle phase of secretion (main group) and 15 patients with the correct rhythm of menstruation (the control group) . The study found a significant increase of the resistance index in the uterine arteries and endometrial thickness reduction in patients of the main group compared to the control group. The group of women received a course of hirudotherapy, after which the resistance index in the uterine arteries and endometrial thickness was not significantly different from the control group thus had noticeable symptomatic reliefs, which indicates the effectiveness of hirudotherapy.

Keywords: hirudotherapy, algo dysmenorrhea,uterine arteries,endometrial sickness.

First page

79

Last page

83

For citation: Mamadjanova Shakhnoz Kahramonovna THE ROLE OF HIRUDOTHERAPY IN TREATING ALGODYSMENORRHEA //New Day in Medicine 8(46)2022 79-83 https://clck.ru/sTAnz

LIST OF REFERENCES:

  1. Zaiei S., Faghihzadeh S., Sohrabvand F., Lamyian M., Emamgholy T. A randomised placebo-controlled trial to determine the effect of vitamin E in treatment of primary dysmenorrhoea. BJOG. 2001;108:1181–3. [PubMed] [Google Scholar]
  2. Jeremy Twigg, Dysmenorhhea current obstetrics and gynaecology-2002; 12:341-344
  3. Ibna  Sina  AlQanoon  fit  tib  vol.  3rd  New Delhi  institute  of history of medicine and medical reaserch-1981;323
  4. Ismael jurjani S.S. Zakheera Khawarazam shahi vol 2nd Lucknow Matba Navil Kishore.NYM, 634,635.
  5. Dawood M.Y. Hormones, prostaglandin and dysmenorrhea. In: Dawood MY, editor. Dysmenorrhea. Baltimore (MD):Williams and Wilkins; 1981. p. 20–52.
  6. Golomb L.M., Solidum A.A., Warren M.P. Primary dysmenorrhea and physical activity. Med Sci Sports Exerc 1998; 30:906–9.
  7. Rosenwaks Z., Seegar-Jones G: Menst0rual pain: its origin and pathogenesis. J Reprod Med 1980; 25:207–12
  8. Bieglmayer C., Hofer G., Kainz C., Reinthaller A., Kopp B., Janisch H: Concentrations of various arachidonic acid metabolites
  9. Jeremy Twigg, Dysmenorhhea current obstetrics and gynaecology-2002; 12:341-344
  10. Proctor M.L., Murphy P.A: Herbal and dietary therapies for primary and secondary Dysmenorrhea. Cochrane Database Syst Rev 2001:CD002124.
  11. Zhu X., Proctor M., Bensoussan A., Smith C.A., Wu E: Chinese herbal medicine for primary dysmenorrhea. Cochrane Database Syst Rev 2007, 17. CD005288.
  12. Aazam M.K. Akseere Aazam Wa Akmal New Delhi Aijaz publication house YMN; 302
  13. Harlow S.D., Park M.: A longitudinal study ofrisk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br. J Obstet Gynaecol 1996; 103:1134– 1142
  14. Lee S.H., Cekanova M., Baek S.J: Multiple mechanisms are involved in 6-gingerolinduced cell growth arrest and apoptosis in human colorectal cancer cells. Mol Carcinog2008, 47:197–208.
  15. Burnett M.A., Antao V., Black A., Feldman K., Grenville A., Lea R, et al. Prevalence of primary dysmenorrhea in Canada. J Obstet Gynaecol Can 2005; 27:765–70

file

download